[1]
Orsini, A. et al. 2022. PRES-like leukoencephalopathy presenting with status epilepticus associated with Brentuximab Vedotin treatment. Acta Biomedica Atenei Parmensis. 92, S4 (Mar. 2022), e2021416. DOI:https://doi.org/10.23750/abm.v92iS4.12665.